Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Other hematologic neoplasm 2Sarcoma 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Colorectal Neoplasms 2Neoplasm Metastasis 1Colorectal Cancer Metastatic 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Maraviroc × Gastrointestinal × Clear all
NCT04721301 2023-10-17

Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial

University Hospital Heidelberg

Phase 1 Completed
50 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT03274804 2022-06-07

PICCASSO

University Hospital Heidelberg

Phase 1 Completed
20 enrolled 12 charts
Gastrointestinal

Colorectal Neoplasms

NCT01736813 2017-03-22

MARACON

National Center for Tumor Diseases, Heidelberg

Completed
12 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡